This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
doi: 10.7554/eLife.18082.

Epidemiology and burden of multidrug-resistant bacterial infection in a developing country

Affiliations

Epidemiology and burden of multidrug-resistant bacterial infection in a developing country

Cherry Lim et al. Elife. .

Abstract

Little is known about the excess mortality caused by multidrug-resistant (MDR) bacterial infection in low- and middle-income countries (LMICs). We retrospectively obtained microbiology laboratory and hospital databases of nine public hospitals in northeast Thailand from 2004 to 2010, and linked these with the national death registry to obtain the 30-day mortality outcome. The 30-day mortality in those with MDR community-acquired bacteraemia, healthcare-associated bacteraemia, and hospital-acquired bacteraemia were 35% (549/1555), 49% (247/500), and 53% (640/1198), respectively. We estimate that 19,122 of 45,209 (43%) deaths in patients with hospital-acquired infection due to MDR bacteria in Thailand in 2010 represented excess mortality caused by MDR. We demonstrate that national statistics on the epidemiology and burden of MDR in LMICs could be improved by integrating information from readily available databases. The prevalence and mortality attributable to MDR in Thailand are high. This is likely to reflect the situation in other LMICs.

Keywords: Acinetobacter; E. coli; Enterococcus; K. pneumoniae; P. aeruginosa; Staphylococcus aureus; antimicrobial resistant; epidemiology; global health.

PubMed Disclaimer

Conflict of interest statement

The authors declare that no competing interests exist.

Figures

Figure 1.
Figure 1.. Location of participating hospitals.
These were situated in (1) Nong Khai, (2) Udon Thani, (3) Nakhon Phanom, (4) Chaiyaphum, (5) Mukdahan, (6) Yasothon, (7) Burirum, (8) Sisaket, and (9) Ubon Ratchathani provinces. DOI: http://dx.doi.org/10.7554/eLife.18082.003
Figure 2.
Figure 2.. Trends in proportions of Staphylococcus aureus bacteraemia being caused by MRSA in Northeast Thailand.
(A) community-acquired, (B) healthcare-associated and (C) hospital-acquired Staphylococcus aureus bacteraemia. DOI: http://dx.doi.org/10.7554/eLife.18082.005
Figure 3.
Figure 3.. Trends in proportions of Escherichia coli bacteraemia being caused by E. coli non-susceptible to extended-spectrum cephalosporins in Northeast Thailand.
(A) community-acquired, (B) healthcare-associated and (C) hospital-acquired E. coli bacteraemia. DOI: http://dx.doi.org/10.7554/eLife.18082.007
Figure 4.
Figure 4.. Trends in proportions of Klebsiella pneumoniae bacteraemia being caused by K. pneumoniae non-susceptible to extended-spectrum cephalosporins in Northeast Thailand.
(A) community-acquired, (B) healthcare-associated and (C) hospital-acquired K. pneumoniae bacteraemia. DOI: http://dx.doi.org/10.7554/eLife.18082.010
Figure 5.
Figure 5.. Trends in proportions of Pseudomonas aeruginosa bacteraemia being caused by P. aeruginosa non-susceptible to carbapenem in Northeast Thailand.
(A) community-acquired, (B) healthcare-associated and (C) hospital-acquired Pseudomonas aeruginosa bacteraemia. DOI: http://dx.doi.org/10.7554/eLife.18082.012
Figure 6.
Figure 6.. Trends in proportions of Acinetobacter spp bacteraemia being caused by Acinetobacter spp non-susceptible to carbapenem in Northeast Thailand.
(A) community-acquired, (B) healthcare-associated and (C) hospital-acquired Acinetobacter spp bacteraemia. DOI: http://dx.doi.org/10.7554/eLife.18082.014
Figure 7.
Figure 7.. Forest plot of mortality in patients with MDR bacteraemia compared with non-MDR bacteraemia in Northeast Thailand.
(A) Community-acquired bacteraemia. (B) Healthcare-associated bacteraemia. (C) Hospital-acquired bacteraemia. DOI: http://dx.doi.org/10.7554/eLife.18082.016

References

    1. Ansari S, Nepal HP, Gautam R, Shrestha S, Neopane P, Gurung G, Chapagain ML. Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal. Antimicrobial Resistance and Infection Control. 2015;4:15. doi: 10.1186/s13756-015-0059-2. - DOI - PMC - PubMed
    1. Benichou J. A review of adjusted estimators of attributable risk. Statistical Methods in Medical Research. 2001;10:195–216. doi: 10.1191/096228001680195157. - DOI - PubMed
    1. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine. 2008;3:17. doi: 10.1186/1751-0473年3月17日. - DOI - PMC - PubMed
    1. Center for Disease Controls and Prevention, U.S. Department of Health and Human Services Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf 2013
    1. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ, Camacho-Cosavalente LA, Castillo-Bravo LI. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Revista Panamericana De Salud Pública. 2008;24:16–24. doi: 10.1590/S1020-49892008000700002. - DOI - PubMed

Publication types

MeSH terms

Full text links
eLife Sciences Publications, Ltd full text link eLife Sciences Publications, Ltd Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /